U.S. Woebot Health closes $90 million Series B round

Woebot Health, a California-based digital therapeutics company, has secured $90 million its Series B round of funding.

The latest financing round, which brings Woebot Health's total investment raised to date to $114 million, was co-led by existing investor JAZZ Venture Partners and Temasek.

The company also received investment from funds and accounts managed by BlackRock Private Equity Partners, Owl Ventures, Mirae Asset Capital, Kicker Ventures, and existing backers, New Enterprise Associates, among others.

Woebot Health will use the new funds to accelerate further development of its relational platform and technologies, advance its lead digital therapeutic candidates, and expand its team and go-to-market activities.